EUVIMEDSkopri EUVIMED
Open access · CC BY-NC-ND 4.0

Tumor Hypoxia and CD8 + T‐Cell Infiltration in Patients With Advanced Laryngeal Cancer

Joshua D Smith, Elizabeth Gensterblum-Miller, David W A Forner, Pratyusha Yalamanchi, Marisa R Buchakjian, Steven B Chinn, Andrew G Shuman, Keith A Casper, Kelly M Malloy, Chaz L Stucken, Scott A Mclean, Michelle L Mierzwa and 7 more

Otolaryngology–Head and Neck Surgery · 2025

DOI: 10.1002/ohn.1291 ↗

At a glance

Journal article in Otolaryngology–Head and Neck Surgery, 2025. Written by Joshua D Smith and 18 co-authors. Institution: Department of Otolaryngology-Head and Neck Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA. Major MEDLINE topics: Laryngeal Neoplasms, CD8-Positive T-Lymphocytes, Lymphocytes, Tumor-Infiltrating, Tumor Hypoxia. Cited 1 times so far (Crossref); 21 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NIDCD NIH HHS.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Objective

We assessed correlations between tumor carbonic anhydrase IX (CAIX) staining, as a marker of tumor hypoxia, and CD8 + T‐cell infiltration in a cohort of patients with advanced laryngeal squamous cell carcinoma undergoing a bioselection approach for definitive treatment. Study Design Retrospective cohort study.

Setting

Tertiary care hospital.

Methods

Patients with stage III to IV laryngeal squamous cell carcinoma treated under a bioselection paradigm were included. Immunohistochemistry for CD8 + T‐cells and CAIX was performed. Nonparametric tests and Kaplan‐Meier survival analyses were used to compare tumor CAIX status by clinicopathologic variables and CD8 + T‐cell infiltration and to evaluate the role of CAIX and combination CAIX/tumor infiltrating lymphocytes (TIL) category on survival.

Results

Our cohort included 92 patients (n = 68 [73.9%] supraglottic). No difference in CAIX staining was seen by tumor subsite, stage, and response to induction chemotherapy (all P > .05). Thirteen (14.1%) tumors were CAIX‐positive and showed significantly lower CD8 + T‐cell infiltration than CAIX‐negative tumors (18 [0‐62] vs 32 [0‐399], P = .028). Combination CAIX/TIL category was significantly associated with the likelihood of response (CAIX−/TIL[high] were less likely to respond) and in the group of responders, was predictive of a higher degree of tumor shrinkage (>80%).

Conclusion

CAIX staining correlates with reduced CD8 + T‐cell infiltration in patients with advanced laryngeal squamous cell carcinoma undergoing bioselection. The combination CAIX/TIL category is associated with the likelihood and degree of response to induction. The utility of CAIX status and other combination immune and hypoxia signatures as a biomarker of induction response and survival merits prospective evaluation.

Subjects

MeSH terms (MEDLINE)

Laryngeal NeoplasmsCD8-Positive T-LymphocytesLymphocytes, Tumor-InfiltratingTumor HypoxiaCarcinoma, Squamous CellHumansMaleRetrospective StudiesFemaleMiddle AgedAgedCarbonic Anhydrase IXNeoplasm StagingImmunohistochemistryAdultAged, 80 and overBiomarkers, TumorAntigens, Neoplasm

Author keywords

TILcarbonic anhydrasehypoxialarynxsquamous cell carcinoma

Substances

Carbonic Anhydrase IXCA9 protein, humanBiomarkers, TumorAntigens, Neoplasm

Authors and institutions

  • Department of Otolaryngology-Head and Neck Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Department of Otolaryngology-Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan, USA.
  • Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA.
  • Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, USA.
  • Department of Internal Medicine, Division of Medical Oncology, University of Michigan, Ann Arbor, Michigan, USA.

Funding

  • NIDCD NIH HHS

Cite

APA

Smith, J. D., Gensterblum-Miller, E., Forner, D. W. A., Yalamanchi, P., Buchakjian, M. R., Chinn, S. B., Shuman, A. G., Casper, K. A., Malloy, K. M., Stucken, C. L., Mclean, S. A., Mierzwa, M. L., Shah, J., Swiecicki, P. L., Worden, F. P., Prince, M. E. P., Spector, M. E., Brenner, J. C., & Heft Neal, M. E. (2025). Tumor Hypoxia and CD8 + T‐Cell Infiltration in Patients With Advanced Laryngeal Cancer. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.1291

Vancouver

Smith JD, Gensterblum-Miller E, Forner DWA, Yalamanchi P, Buchakjian MR, Chinn SB, et al. Tumor Hypoxia and CD8 + T‐Cell Infiltration in Patients With Advanced Laryngeal Cancer. Otolaryngology–Head and Neck Surgery. 2025. doi:10.1002/ohn.1291

BibTeX
@article{Smith2025,
  author = {Smith, Joshua D and Gensterblum-Miller, Elizabeth and Forner, David W A and Yalamanchi, Pratyusha and Buchakjian, Marisa R and Chinn, Steven B and Shuman, Andrew G and Casper, Keith A and Malloy, Kelly M and Stucken, Chaz L and Mclean, Scott A and Mierzwa, Michelle L and Shah, Jennifer and Swiecicki, Paul L and Worden, Francis P and Prince, Mark E P and Spector, Matthew E and Brenner, J Chad and Heft Neal, Molly E},
  title = {Tumor Hypoxia and CD8 + T‐Cell Infiltration in Patients With Advanced Laryngeal Cancer},
  journal = {Otolaryngology–Head and Neck Surgery},
  year = {2025},
  doi = {10.1002/ohn.1291}
}
Start for free →